U.S. stocks slipped into the red today, with the Nasdaq Composite edging down 0.05% to 16,823.17. The Dow declined nearly 0.4 ...

Alnylam Pharmaceuticals ALNY -3.78% Get Free Report has outperformed the market over the past 15 years by 8.52% on an ...

FDA and Novo Nordisk warn about counterfeit Ozempic in the U.S. with fake serial numbers, posing risks due to unknown ...

Buying $1000 In CNC: If an investor had bought $1000 of CNC stock 20 years ago, it would be worth $8,812.17 today based on a ...

BofA Securities analyst maintains Buy rating on Netflix with $1,175 target. Predicts continued positive subscriber and ...

Buying $1000 In CBRE: If an investor had bought $1000 of CBRE stock 5 years ago, it would be worth $2,666.97 today based on a ...

Looking into the current session, Apple Inc. AAPL shares are trading at $202.20, after a 0.16% drop. Over the past month, the ...

Bristol Myers' Camzyos missed goals in a Phase 3 nHCM trial, showing no significant benefits over placebo but raised no new ...

The general mood among these heavyweight investors is divided, with 36% leaning bullish and 54% bearish. Among these notable ...

OpenAI and X feud over social media dominance as Altman and Musk's disagreements continue. X remains popular despite ...

Interactive Brokers releases its first-quarter results after Tuesday's closing bell. Here's a look at the key figures from ...

Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems.